Freeze-Thaw Sensitivity in Reconstituted Injectable Products
Freeze-Thaw Sensitivity in Reconstituted Injectable Products Freeze-Thaw Sensitivity in Reconstituted Injectable Products: Stability Strategies for Regulatory Compliance Reconstituted injectable products—formed by mixing lyophilized powders with a diluent just before use—are widely used in parenteral formulations, including antibiotics, biologics, peptides, and oncology agents. These products often have limited post-reconstitution shelf life and increased sensitivity to environmental…
Read More “Freeze-Thaw Sensitivity in Reconstituted Injectable Products” »